. Author manuscript; available in PMC: 2006 Sep 5.

Published in final edited form as: J Natl Cancer Inst. 1999 Dec 15;91(24):2087–2095. doi: 10.1093/jnci/91.24.2087

Table 2.

Prevalence of 9p LOH and 17p LOH in patients with and without flow-cytometric abnormalities^*

Patients with increased 4N and/or aneuploidy				Patients with normal flow-cytometric characteristic (diploid only)
	9p het	9p LOH	Total		9p het	9p LOH	Total
17p het	1 (3)^†	2 (6)	3 (9)	17p het	12 (52)	7 (30)	19 (83)
17pLOH	8 (24)	22 (67)	30 (91)	17p LOH	1 (4)	3 (13)	4 (17)
Total	9 (27)	24 (73)	33^‡	Total	13 (57)	10 (43)	23‡

LOH = loss of heterozygosity; het = heterozygous; increased 4N refers to samples with more than 6% of cells containing 4N DNA.

^†

Numbers of patients (% of total), rounding of totals is done after adding the nonrounded percentages).

^‡

Includes only the 56 patients who were informative for markers on both 9p and 17p.